Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00398580 | 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men | PHASE2 | COMPLETED | 43 | — | — | Oct 1, 2006 | Oct 1, 2007 | May 30, 2017 | 7 | United States |
| NCT00400335 | Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride | PHASE1 | COMPLETED | 60 | — | — | Oct 1, 2006 | - | Jun 4, 2012 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| Nanomilled testosterone | DRUG | - |
| Nanomilled dutasteride | DRUG | - |
| commercially available dutasteride | DRUG | - |
Inclusion criteria: * Have a diagnosis of primary or secondary hypogonadism. * Have very low testosterone levels on 2 separate days. * Have a BMI within range of 18.5-35kg/m2. * Have not taken dutasteride for one year, or finasteride for the past 3 months. Exclusion criteria: * Have had or have b...